Evidence map›Paper›PMID 29073951›Full record

ArticleJournal of the American College of Cardiology2017

Cardiac Effects of Highly Active Antiretroviral Therapy in Perinatally HIV-Infected Children: The CHAART-2 Study.

Steven E Lipshultz, James D Wilkinson, Bruce Thompson, Irene Cheng, David A Briston, William T Shearer, E John Orav, Joslyn A Westphal, Tracie L Miller, Steven D Colan and 1 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of the American College of Cardiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Steven E LipshultzWayne State University School of Medicine, Detroit, Michigan; Children's Hospital of Michigan, Detroit, Michigan. Electronic address: slipshultz@med.wayne.edu.
James D WilkinsonWayne State University School of Medicine, Detroit, Michigan.
Bruce ThompsonTheta Hat Statistical Consultants, Owings Mills, Maryland.
Irene ChengTheta Hat Statistical Consultants, Owings Mills, Maryland.
David A BristonOhio State University Medical Center and Nationwide Children's Hospital, Columbus, Ohio.
William T ShearerBaylor College of Medicine and Texas Children's Hospital, Houston, Texas.
E John OravBrigham and Women's Hospital, Boston, Massachusetts.
Joslyn A WestphalWayne State University School of Medicine, Detroit, Michigan.
Tracie L MillerUniversity of Miami Miller School of Medicine, Miami, Florida.
Steven D ColanBoston Children's Hospital, Boston, Massachusetts.
CHAART-2 Investigator Group

Funding

HAART Associated Cardiotoxicity in HIV-Infected ChildrenR01HL078522 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LIPSHULTZ, STEVEN EDWARD · 2004 to 2008
$2.0M
NHLBI NIH HHS R01 HL078522
6 · The paper itself

Abstract

backgroundBefore the introduction of highly active antiretroviral therapy (HAART), cardiac mortality and morbidity were common in HIV-infected children.

objectivesThis study sought to identify long-term cardiovascular effects of HAART in HIV-infected children.

methodsThe CHAART-2 (HAART-Associated Cardiotoxicity in HIV-Infected Children) study prospectively compared 148 echocardiograms from 74 HAART-exposed children to 860 echocardiograms from 140 HAART-unexposed but HIV-infected children from the Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P

resultsComparing the HAART-exposed and HAART-unexposed groups, any HAART exposure was positively associated with left ventricular (LV) fractional shortening (z-score for difference = 1.07; p = 0.02) and HAART exposure duration (z-score difference per year = 0.17; p = 0.003. LV mass was negatively associated with any HAART exposure (z-score difference = -0.64; p = 0.01) as was septal thickness (z-score difference = -0.93; p = 0.001). Duration of HAART exposure was negatively associated with LV end-systolic dimension and heart rate (z-score difference per year= -0.11; p = 0.05; and z-score difference per year = -0.10; p = 0.002, respectively). During 11 years of follow-up, in the HAART-exposed group, LV mass and LV end-diastolic septal thickness were lower whereas LV contractility and LV fractional shortening were higher when compared to the HAART-unexposed group.

conclusionsCardiac structure and function were better in perinatally HIV-infected children exposed to HAART than in those of similar children from the pre-HAART era but did decline over time. Evidence-based strategies for cardiovascular monitoring are needed to inform treatment decisions to improve long-term cardiovascular health.

Indexed as

AdolescentAdultAntiretroviral Therapy, Highly ActiveCardiotoxinsChildChild, PreschoolCohort StudiesCross-Sectional StudiesFemaleFollow-Up StudiesHIV InfectionsHumansHypertrophy, Left VentricularLongitudinal StudiesMalePerinatal CareCardiotoxinsantiretroviral therapycardiomyopathyHIVpediatric

Identifiers

PMID29073951
PMCPMC5687306

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.